James M McKiernan MD

PubMed

• Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer.
  Casey R Ager, Aleksandar Obradovic, Patrick McCann, Matthew Chaimowitz, Alexander L E Wang
  Medrxiv. 2025-03-31
• The Impact of American Board of Urology Certification on Post-operative Outcomes for Patients: Assessing National Trends.
  Gina M Badalato, Saud Khan, Prakash Gorroochurn, Gary E Lemack, James M McKiernan
  Urology. 2025-03-05
• Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.
  Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, Leslie Ballas, Rick Bangs
  Bladder Cancer. 2025-02-24

Journal Articles

• Impact of synchronous metastasis distribution on cancer-specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy  
  Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner..., Urol, 7/22/2014
• Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer  
  Stevenson SM, Danzig MR, Ghandour RA, Deibert CM, Joel Decastro G, Benson MC, McKiernan JM, Urol Oncol, 7/3/2014
• Phase II Trial of Intravesical Nanoparticle Albumin-Bound (nab-) Paclitaxel for the Treatment of Non-Muscle Invasive Urothelial Carcinoma of the Bladder after BCG Trea...  
  McKiernan JM, Holder DD, Ghandour RA, Barlow LJ, Ahn JJ, Kates M, Badalato GM, Roychoudhury A, Decastro GJ, Benson MC, J Urol, 7/1/2014
• Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)  
  Martinez-Salamanca JI1, Linares E, Gonzalez J, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, Haferkamp A, Hohenfellner M, Huang ..., Curr Urol Rep, 5/1/2014
• In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States  
  Kates M, Gorin MA, Deibert CM, Pierorazio PM, Schoenberg MP, McKiernan JM, Bivalacqua TJ, Urol Oncol, 1/1/2014
• Comparison of robotic assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical margins  
  Shapiro EY, Scarberry K, Patel T, Bergman A, Ahn J, Sahi N, Roychoudhury A, Deutsch I, McKiernan JM, Benson MC, Badani KK, J Endourol, 9/17/2013
• Cytoreductive nephrectomy for metastatic renal cell carcinoma  
  McKiernan J, Wood CG, Urology, 8/1/2013
• Impact of Histologic Subtype on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus  
  Tilki D, Nguyen HG, Dall'era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie T..., Eur Urol, 7/1/2013
• Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an...  
  Ritch CR, Morrison BF, Hruby G, Coard KC, Mayhew R, Aiken W, Benson MC, McKiernan JM, BJU Int, 4/1/2013
• Long-term survival outcomes with intravesical docetaxel for recurrent nonmuscle invasive bladder cancer after previous bacillus Calmette-Guérin therapy  
  Barlow L, McKiernan JM, Benson MC, Journal of Urol, 3/1/2013
• A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer  
  Burke JM, Lamm DL, Meng MV, Nemunaitis JJ, Stephenson JJ, Arseneau JC, Aimi J, Lerner S, Yeung AW, Kazarian T, Maslyar DJ, McKiernan JM, J Urol, 12/1/2012
• Partial nephrectomy online: a preliminary evaluation of the quality of health information on the Internet  
  Fast AM, Deibert CM, Boyer C, Hruby GW, McKiernan JM, BJU Int, 12/1/2012
• Outcomes of Intrarenal Bacillus Calmette-Guerin/Interferon-alpha2B for Biopsy-Proven Upper-Tract Carcinoma in Situ  
  Shapiro EY, Lipsky MJ, Cha DY, McKiernan JM, Benson MC, Gupta M, J Endourol, 10/9/2012
• The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma  
  Sadeghi N, Badalato GM, Hruby G, Kates M, McKiernan JM, Can J Urol, 10/1/2012
• Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer  
  Shen J, Hruby GW, McKiernan JM, Gurvich I, Lipsky MJ, Benson MC, Santella RM, Prostate, 9/15/2012
• Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion  
  Godfrey MS, Badalato GM, Hruby GW, Razmjoo M, McKiernan JM, BJU Int, 9/1/2012
• Does Absolute Neutrophil Count Predict High Tumor Grade in African-American Men with Prostate Cancer?  
  Sadeghi N, Grann V, McKiernan JM, The Prostate, 3/1/2012
• DNA Methylation Changes Correlate with Gleason Score and Tumor Stage in Prostate Cancer  
  Delgado-Cruzata L, Hruby GW, Gonzalez K, McKiernan J, Benson MC, Santella RM, Shen J, DNA Cell Biol, 2/1/2012
• Tumour diameter and decreased preoperative estimated glomerular filtration rate are independently correlated in patients with renal cell carcinoma  
  Donin NM, Suh LK, Barlow L, Hruby GW, Newhouse J, McKiernan J, BJU Int, 2/1/2012
• Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy  
  Wosnitzer MS, Domingo-Domenech J, Castillo-Martin M, Ritch C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM, Cordon-Cardo C, Journal of Urol, 11/1/2011
• Persistent overuse of radical nephrectomy in the elderly  
  Kates M, Badalato G, Pitman M, McKiernan J, Urology, 9/1/2011
• A phase I trial of intravesical nanoparticle albumin-bound (nab-)paclitaxel (Abraxane® ABI-007) in the treatment of BCG refractory non-muscle-invasive bladder cancer  
  McKiernan JM, Barlow LJ, Laudano MA, Mann MJ, Petrylak DP, Benson MC, Journal of Urol, 8/1/2011
• Diagnostic radiation exposure risk in a contemporary cohort of male patients with germ cell tumor  
  Silva MV, Motamedinia P, Badalato GM, Hruby G, McKiernan JM, Journal of Urol, 2/1/2011
• Maximizing intravesical therapy options: is there an advantage to the administration of perioperative mitomycin C prior to an induction course of BCG?  
  Badalato GM, Hruby G, Razmjoo M, McKiernan JM, Can J Urol, 1/1/2011
• Does the presence of muscularis propria on transurethral resection of bladder tumour specimens affect the rate of upstaging in cT1 bladder cancer?  
  Badalato G, Patel T, Hruby G, McKiernan J, BJU Int, 12/22/2010
• Join now to see all

Books/Book Chapters

• Staging Manual, Genitourinary System 
  Chapter: American Joint Committee on Cancer TNM 
  McKiernan JMEdition 7th,2009
• Campbell's Urology 
  Chapter: Continent Cutaneous Urinary Diversion 
  Benson MC, McKiernan JM, Olsson CAEdition 9th,2006
• Campbell's Urology 
  Chapter: Surgery of Testicular Neoplasms 
  Sheinfeld J, McKiernan JM, Bosl GJEdition 8th,2002